PRESS RELEASE published on 10/19/2023 at 15:57, 2 years 8 months ago Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): BUY
PRESS RELEASE published on 09/14/2023 at 22:06, 2 years 9 months ago Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
PRESS RELEASE published on 09/13/2023 at 13:01, 2 years 9 months ago Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
PRESS RELEASE published on 05/03/2023 at 13:01, 3 years 1 month ago Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
PRESS RELEASE published on 04/10/2023 at 13:05, 3 years 2 months ago Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
PRESS RELEASE published on 03/22/2023 at 12:04, 3 years 2 months ago Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions
PRESS RELEASE published on 03/14/2023 at 12:05, 3 years 3 months ago Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit
PRESS RELEASE published on 03/08/2023 at 13:05, 3 years 3 months ago Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes
PRESS RELEASE published on 03/02/2023 at 13:05, 3 years 3 months ago Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences
PRESS RELEASE published on 01/30/2023 at 13:35, 3 years 4 months ago Sernova Announces Advancements with its Novel Cell Pouch System(TM) to Preserve Thyroid Function Following Total Thyroidectomy
Published on 06/20/2026 at 01:00, 7 hours 40 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 8 hours 40 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 4 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 7 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 7 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 06:00, 2 hours 40 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 12 hours 23 minutes ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 12 hours 23 minutes ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 13 hours 39 minutes ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 13 hours 7 minutes ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 13 hours 7 minutes ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 13 hours 16 minutes ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 13 hours 16 minutes ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
